PortfoliosLab logo
INO vs. MDU
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INO and MDU is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

INO vs. MDU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inovio Pharmaceuticals, Inc. (INO) and MDU Resources Group, Inc. (MDU). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

INO:

-1.09

MDU:

1.08

Sortino Ratio

INO:

-2.50

MDU:

1.68

Omega Ratio

INO:

0.68

MDU:

1.21

Calmar Ratio

INO:

-0.84

MDU:

1.40

Martin Ratio

INO:

-1.29

MDU:

3.10

Ulcer Index

INO:

65.25%

MDU:

9.67%

Daily Std Dev

INO:

76.36%

MDU:

27.12%

Max Drawdown

INO:

-99.94%

MDU:

-62.17%

Current Drawdown

INO:

-99.91%

MDU:

-10.60%

Fundamentals

Market Cap

INO:

$75.18M

MDU:

$3.63B

EPS

INO:

-$3.95

MDU:

$0.91

PEG Ratio

INO:

0.00

MDU:

2.26

PS Ratio

INO:

265.57

MDU:

1.97

PB Ratio

INO:

1.10

MDU:

1.30

Total Revenue (TTM)

INO:

$217.76K

MDU:

$3.31B

Gross Profit (TTM)

INO:

-$1.39M

MDU:

$468.25M

EBITDA (TTM)

INO:

-$25.12B

MDU:

$470.86M

Returns By Period

In the year-to-date period, INO achieves a 13.11% return, which is significantly higher than MDU's -0.67% return. Over the past 10 years, INO has underperformed MDU with an annualized return of -32.52%, while MDU has yielded a comparatively higher 11.83% annualized return.


INO

YTD

13.11%

1M

18.97%

6M

-49.20%

1Y

-82.75%

3Y*

-54.90%

5Y*

-59.48%

10Y*

-32.52%

MDU

YTD

-0.67%

1M

5.90%

6M

-3.11%

1Y

28.98%

3Y*

24.46%

5Y*

21.05%

10Y*

11.83%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Inovio Pharmaceuticals, Inc.

MDU Resources Group, Inc.

Risk-Adjusted Performance

INO vs. MDU — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INO
The Risk-Adjusted Performance Rank of INO is 44
Overall Rank
The Sharpe Ratio Rank of INO is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of INO is 11
Sortino Ratio Rank
The Omega Ratio Rank of INO is 22
Omega Ratio Rank
The Calmar Ratio Rank of INO is 44
Calmar Ratio Rank
The Martin Ratio Rank of INO is 1313
Martin Ratio Rank

MDU
The Risk-Adjusted Performance Rank of MDU is 8282
Overall Rank
The Sharpe Ratio Rank of MDU is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of MDU is 8181
Sortino Ratio Rank
The Omega Ratio Rank of MDU is 7878
Omega Ratio Rank
The Calmar Ratio Rank of MDU is 8989
Calmar Ratio Rank
The Martin Ratio Rank of MDU is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INO vs. MDU - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inovio Pharmaceuticals, Inc. (INO) and MDU Resources Group, Inc. (MDU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current INO Sharpe Ratio is -1.09, which is lower than the MDU Sharpe Ratio of 1.08. The chart below compares the historical Sharpe Ratios of INO and MDU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

INO vs. MDU - Dividend Comparison

INO has not paid dividends to shareholders, while MDU's dividend yield for the trailing twelve months is around 2.26%.


TTM20242023202220212020201920182017201620152014
INO
Inovio Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.28%0.00%0.00%0.00%
MDU
MDU Resources Group, Inc.
2.26%1.89%4.06%2.88%2.77%3.17%2.74%3.33%2.88%2.62%4.01%3.04%

Drawdowns

INO vs. MDU - Drawdown Comparison

The maximum INO drawdown since its inception was -99.94%, which is greater than MDU's maximum drawdown of -62.17%. Use the drawdown chart below to compare losses from any high point for INO and MDU. For additional features, visit the drawdowns tool.


Loading data...

Volatility

INO vs. MDU - Volatility Comparison

Inovio Pharmaceuticals, Inc. (INO) has a higher volatility of 15.78% compared to MDU Resources Group, Inc. (MDU) at 7.14%. This indicates that INO's price experiences larger fluctuations and is considered to be riskier than MDU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

INO vs. MDU - Financials Comparison

This section allows you to compare key financial metrics between Inovio Pharmaceuticals, Inc. and MDU Resources Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20212022202320242025
116.99K
674.83M
(INO) Total Revenue
(MDU) Total Revenue
Values in USD except per share items